Patent · US Active

Compounds for inhibiting KSP kinesin activity

US7608643B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2006
Grant dateOct 27, 2009
Priority date
Expiry dateAug 4, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof:The present invention provides compositions comprising these compounds that are useful for treating cellular proliferative diseases or disorders associated with KSP kinesin activity and for inhibiting KSP kinesin activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.